STAT5A |
STAT5A, STAT5: Signal transducer and activator of transcription 5A |
YES1 |
YES1, YES: Proto-oncogene tyrosine-protein kinase Yes |
158.000 |
Evidence |
|
GNAI3 |
GNAI3: Guanine nucleotide-binding protein G(k) subunit alpha |
SSTR2 |
SSTR2: Somatostatin receptor type 2 |
158.000 |
Evidence |
|
CBL |
CBL, CBL2, RNF55: E3 ubiquitin-protein ligase CBL |
SRC |
SRC, SRC1: Proto-oncogene tyrosine-protein kinase Src |
156.000 |
Evidence |
|
PROC |
PROC: Vitamin K-dependent protein C precursor |
C6 |
C6: Complement component C6 precursor |
156.000 |
Evidence |
|
BCL2 |
BCL2: Apoptosis regulator Bcl-2 |
BCL2L1 |
BCL2L1, BCL2L, BCLX: Apoptosis regulator Bcl-X |
156.000 |
Evidence |
|
MAPK8 |
MAPK8, JNK1, PRKM8: Mitogen-activated protein kinase 8 |
DUSP16 |
DUSP16, KIAA1700, MKP7: Dual specificity protein phosphatase 16 |
156.000 |
Evidence |
|
PTK2B |
PTK2B, FAK2, PYK2, RAFTK: Protein tyrosine kinase 2 beta |
LCK |
LCK: Proto-oncogene tyrosine-protein kinase LCK |
156.000 |
Evidence |
|
PTPN6 |
PTPN6, HCP, PTP1C: Tyrosine-protein phosphatase non-receptor type 6 |
SYK |
SYK: Tyrosine-protein kinase SYK |
156.000 |
Evidence |
|
BMX |
IPI00514142 |
STAT3 |
|
156.000 |
Evidence |
|
LCK |
LCK: Proto-oncogene tyrosine-protein kinase LCK |
STAT3 |
|
156.000 |
Evidence |
|
PTPN6 |
PTPN6, HCP, PTP1C: Tyrosine-protein phosphatase non-receptor type 6 |
LCK |
LCK: Proto-oncogene tyrosine-protein kinase LCK |
156.000 |
Evidence |
|
GRB2 |
GRB2, ASH: Growth factor receptor-bound protein 2 |
LCK |
LCK: Proto-oncogene tyrosine-protein kinase LCK |
156.000 |
Evidence |
|
KLK3 |
KLK3, APS: Prostate-specific antigen precursor |
SERPINF2 |
SERPINF2, AAP, PLI: Alpha-2-antiplasmin precursor |
156.000 |
Evidence |
|
STAT3 |
|
JAK1 |
|
156.000 |
Evidence |
|
PTPN6 |
PTPN6, HCP, PTP1C: Tyrosine-protein phosphatase non-receptor type 6 |
LYN |
LYN: Tyrosine-protein kinase Lyn |
156.000 |
Evidence |
|
BTK |
BTK, AGMX1, ATK, BPK: Tyrosine-protein kinase BTK |
STAT3 |
|
156.000 |
Evidence |
|
HCK |
IPI00029769 |
ITK |
ITK, EMT, LYK: Tyrosine-protein kinase ITK/TSK |
156.000 |
Evidence |
|
STAT3 |
|
SRC |
SRC, SRC1: Proto-oncogene tyrosine-protein kinase Src |
156.000 |
Evidence |
|
SYK |
SYK: Tyrosine-protein kinase SYK |
STAT3 |
|
156.000 |
Evidence |
|
BCL2L1 |
BCL2L1, BCL2L, BCLX: Apoptosis regulator Bcl-X |
MCL1 |
MCL1: Induced myeloid leukemia cell differentiation protein Mcl-1 |
156.000 |
Evidence |
|
GNAI3 |
GNAI3: Guanine nucleotide-binding protein G(k) subunit alpha |
SSTR1 |
SSTR1: Somatostatin receptor type 1 |
155.000 |
Evidence |
|
ADRA2B |
ADRA2B, ADRA2L1, ADRA2RL1: Alpha-2B adrenergic receptor |
GNAI1 |
GNAI1: Guanine nucleotide-binding protein G(i), alpha-1 subunit |
155.000 |
Evidence |
|
GNAI3 |
GNAI3: Guanine nucleotide-binding protein G(k) subunit alpha |
LHCGR |
LHCGR, LCGR, LGR2, LHRHR: Lutropin-choriogonadotropic hormone receptor precursor |
155.000 |
Evidence |
|
EIF3S4 |
EIF3S4: Eukaryotic translation initiation factor 3 subunit 4 |
RPS5 |
RPS5: 40S ribosomal protein S5 |
155.000 |
Evidence |
|
PSMD7 |
PSMD7, MOV34L: 26S proteasome non-ATPase regulatory subunit 7 |
PSMD13 |
PSMD13: 26S proteasome non-ATPase regulatory subunit 13 |
154.000 |
Evidence |
O
|